4D Molecular Therapeutics Inc (NASDAQ: FDMT) Is A Chance For Risk-Tolerant Investors
4D Molecular Therapeutics Inc (NASDAQ:FDMT)’s traded shares stood at 0.64 million during the latest session, with the company’s beta value hitting 2.89. At the last